Abbott Laboratories

NYSE:ABT   3:59:57 PM EDT
98.37
-1.47 (-1.47%)
Products

FDA Approves Abbott's New Spinal Cord Stimulation Device Provides Tailored Relief To Multiple Pain Areas And Adds More Treatment Options For Evolving Pain Conditions

Published: 08/23/2022 13:16 GMT
Abbott Laboratories (ABT) - FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions.